Company Filing History:
Years Active: 2017-2023
Title: Innovations by Young-Deug Kim
Introduction
Young-Deug Kim is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for various diseases. With a total of five patents to his name, his work has the potential to impact medical treatments significantly.
Latest Patents
One of his latest patents is the PEGylated interferon-beta variant. This invention provides a PEGylated IFN-β variant and a composition for preventing or treating hyperproliferative diseases, inflammatory diseases, autoimmune diseases, or viral infectious diseases. The composition comprises the PEGylated IFN-β variant as an effective ingredient. This variant exhibits excellent anti-viral efficacy, immune regulatory function, and anti-cell growth efficacy due to its superior pharmacokinetic properties compared to native and non-PEGylated IFN-β variants. It offers good patient convenience in terms of administration and significantly increases the half-life in blood over existing interferon formulations.
Another significant patent is related to a genetic marker for early breast cancer prognosis prediction and diagnosis. This invention pertains to a gene that can predict or diagnose the prognosis of early-stage breast cancer. Specifically, it includes markers such as TRBC1, BTN3A2, or HLA-DPA1, which provide essential information for predicting or diagnosing breast cancer prognosis. This genetic marker allows for better treatment direction, including decisions on the necessity of anticancer therapy.
Career Highlights
Throughout his career, Young-Deug Kim has worked with various companies, including Abion Inc. and Gencurix Inc. His work in these organizations has contributed to advancements in medical technology and therapeutic solutions.
Collaborations
Some of his notable coworkers include Young Kee Shin and En Sel Oh, who have collaborated with him on various projects in the field of biotechnology.
Conclusion
Young-Deug Kim's innovative work in biotechnology, particularly in the development of therapeutic agents and genetic markers, showcases his significant contributions to medical science. His patents reflect a commitment to improving patient outcomes and advancing treatment methodologies.